Name: UMIN ID:
Unique ID issued by UMIN | UMIN000042892 |
---|---|
Receipt number | R000048960 |
Scientific Title | Efficacy and safety of irinotecan after chemotherapy in combination with immunotherapy in patients with extensive stage small cell lung cancer: a phase II trial |
Date of disclosure of the study information | 2021/01/05 |
Last modified on | 2022/01/24 12:45:20 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2021/01/04 11:01:50 | ||
2 | Update | 2021/01/05 16:26:17 | Date of disclosure of the study information |
|
3 | Update | 2021/01/05 16:27:05 | Recruitment status Date of IRB Anticipated trial start date |
|
4 | Update | 2021/01/05 16:30:06 | Recruitment status |
|
5 | Update | 2021/01/05 16:30:48 | Recruitment status |
|
6 | Update | 2021/01/05 16:31:27 | Recruitment status Anticipated trial start date |
|
7 | Update | 2022/01/24 12:45:20 | Recruitment status |